---
title: SR 634. Lung Cancer; recognize burden in the United States and State of Georgia; support prevention, early detection, and timely intervention to improve patient outcomes
collection: bills
id: 2025-2026/sr634
cite_as: SR 634, 2025-2026 Regular Session (Ga.)
canonical_url: https://georgiacommons.org/bills/2025-2026/sr634
md_url: https://georgiacommons.org/bills/2025-2026/sr634.md
text_url: https://georgiacommons.org/bills/2025-2026/sr634/text
source_url: https://www.legis.ga.gov/legislation/72499
date: 2026-01-29
status: passed
corpus_version: bills-2026-09-13
license: Public record of the Georgia General Assembly, via LegiScan; see about.md
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/bills/2025-2026.md
previous: https://georgiacommons.org/bills/2025-2026/sr633.md
next: https://georgiacommons.org/bills/2025-2026/sr635.md
index: https://georgiacommons.org/bills/index.md
omitted: votes and history
omitted_chars: 94
omitted_url: https://georgiacommons.org/bills/2025-2026/sr634.md?full=1
bill_number: SR 634
session: 2025-2026 Regular Session
session_slug: 2025-2026
chamber: Senate
bill_type: resolution
status_date: 2026-01-29
last_action: Senate Read and Adopted
sponsors:
  - Chuck Hufstetler
  - Bo Hatchett
  - Max Burns
  - Ben Watson
  - Carden Summers
  - John Albers
  - Larry Walker
  - Shawn Still
  - Jason Anavitarte
  - Blake Tillery
  - Frank Ginn
  - Clint Dixon
  - Steve Gooch
  - Kay Kirkpatrick
  - Lee Anderson
  - Billy Hickman
  - Marty Harbin
  - Bill Cowsert
  - Chuck Payne
  - Matt Brass
  - Timothy Bearden
  - Russ Goodman
text_version: Enrolled
has_text: true
legiscan_url: https://legiscan.com/GA/bill/SR634/2025
upstream_id: 2100308
summaries_model: claude-sonnet-5
topic_tags:
  - lung cancer
  - public health
  - cancer disparities
  - veterans health
  - medical technology
---

# SR 634. Lung Cancer; recognize burden in the United States and State of Georgia; support prevention, early detection, and timely intervention to improve patient outcomes

## Text

Senate Resolution 634
By: Senators Hufstetler of the 52nd, Hatchett of the 50th, Burns of the 23rd, Watson of the
1st, Summers of the 13th and others
A RESOLUTION
Recognizing the burden of lung cancer in the United States and the State of Georgia;
supporting prevention, early detection, and timely intervention to improve patient outcomes;
addressing disparities in care; and commending Intuitive for its leadership in advancing lung
cancer care through innovations such as the Ion robotic endoluminal system; and for other
purposes.
WHEREAS, lung cancer is the leading cause of cancer-related death in the United States,
taking the lives of nearly 361 Americans each day and accounting for approximately 125,070
deaths annually-nearly as many deaths as colorectal (53,010), breast (42,780), and prostate
(32,520) cancers combined; and
WHEREAS, about every two minutes someone in the United States is diagnosed with lung
cancer, and close to 227,000 people were expected to be diagnosed in 2024; and
WHEREAS, there are a variety of risk factors associated with lung cancer, including
smoking, exposure to radon gas, air pollution, secondhand smoke and military service-related
exposure; and
WHEREAS, even non-tobacco users get lung cancer, with approximately 20 percent of new
cases occurring in people who have never smoked; and
WHEREAS, veterans have a higher rate of lung cancer and are 25 percent more likely to
receive a lung cancer diagnosis compared to the general population; and
WHEREAS, the burden of lung cancer is not distributed equally: people of color, particularly
Black and Indigenous Americans, are less likely to be diagnosed early, less likely to receive
surgical treatment, and face significantly lower survival rates compared to white Americans;
and
WHEREAS, lung cancer has one of the lowest five-year survival rates of all major cancers,
largely because cases are frequently diagnosed at later stages, when effective treatment
options are limited; and
WHEREAS, the national five-year survival rate after a lung cancer diagnosis is only 29.7
percent, and in Georgia is 26.2 percent-ranking Georgia 30th among 39 states with available
data and placing it in the below average tier; and
WHEREAS, only 28.1 percent of lung cancer cases nationally are diagnosed at an early
stage, when the five-year survival rate rises to 65 percent; unfortunately, 43.1 percent of
cases are diagnosed at a late stage, when survival drops to just 10 percent; and
WHEREAS, in Georgia, only 26.9 percent of lung cancer cases are diagnosed early, which
is lower than the national rate and ranks Georgia 38th among the 50 states, placing it in the
average tier for early diagnosis; and
WHEREAS, the rate of new lung cancer cases in Georgia is 55.7 per 100,000, higher than
the national rate of 52.8 per 100,000 and placing Georgia 29th among all states; and
WHEREAS, surgery is the most effective treatment for early-stage lung cancer that has not
spread, yet only about 20.7 percent of cases nationally undergo surgery, with rates similarly
low in Georgia, partly due to late diagnosis; and
WHEREAS, early-stage lung cancers present unique clinical challenges, with over 70
percent located in the outer third of the lung, 64 percent in the upper lobes, and 51 percent
lacking a leading airway, making them very difficult to reach and biopsy using traditional
technology; and
WHEREAS, Intuitive's Ion robotic endoluminal system is designed with the smallest outer
diameter in its class, maximizing physician reach into the lung periphery and enabling
minimally invasive biopsies of small, hard-to-reach nodules, thereby empowering clinicians
to overcome anatomical challenges and achieve more accurate, earlier diagnoses; and
WHEREAS, Ion has the potential to improve survival rates and reduce overall healthcare
costs by increasing the number of patients who can be diagnosed at an early and treatable
stage; and
WHEREAS, expanding access to cutting-edge technology like Ion and the da Vinci surgical
system supports Georgia healthcare teams, including those serving active military and
veterans, in their fight against lung cancer, benefits patients regardless of risk factors, and
aligns with statewide commitments to elevate patient care and address health disparities.
NOW, THEREFORE, BE IT RESOLVED BY THE SENATE that the members of this body
recognize lung cancer as a critical public health concern and support efforts to improve
prevention, early detection, diagnosis, and intervention, while addressing disparities in care
and outcomes.
BE IT FURTHER RESOLVED that the members commend Intuitive for its leadership and
innovation in advancing lung cancer diagnostic care through the Ion robotic endoluminal
system and surgical care through the da Vinci surgical system.
BE IT FURTHER RESOLVED that the Secretary of the Senate is authorized and directed
to make an appropriate copy of this resolution available for distribution to Intuitive.

## Summaries written by Georgia Commons

The following was written by claude-sonnet-5 from the text above and is not part of the resolution. Quote the text, not the summary.

A Georgia Senate resolution recognizes the toll of lung cancer nationally and in Georgia, calls for better prevention and early detection, and praises the medical device company Intuitive for its lung cancer diagnostic technology.

### Plain-language summary

This resolution does not change Georgia law. It is a formal statement from the Georgia Senate acknowledging that lung cancer is the leading cause of cancer death in the United States and that Georgia's survival and early-detection rates lag behind the national average. It cites statistics on smoking and non-smoking cases, veterans' higher diagnosis rates, and racial disparities in diagnosis and treatment.
The resolution states the Senate's support for improving prevention, early detection, diagnosis, and treatment of lung cancer while addressing disparities in care. It also commends Intuitive, a medical technology company, for its Ion robotic endoluminal system and da Vinci surgical system, which are used to biopsy hard-to-reach lung nodules. The Secretary of the Senate is directed to send a copy of the resolution to Intuitive.

### What it does

- Formally recognizes lung cancer as a critical public health concern in the United States and Georgia, citing mortality and diagnosis statistics.
- States Senate support for improved prevention, early detection, diagnosis, and treatment of lung cancer.
- States Senate support for addressing racial and other disparities in lung cancer diagnosis, treatment, and survival.
- Commends the company Intuitive for its Ion robotic endoluminal system and da Vinci surgical system used in lung cancer care.
- Directs the Secretary of the Senate to send a copy of the resolution to Intuitive.
- Creates no new law, funding, or requirement; it is a statement of the Senate's position rather than a binding rule.

### Who it affects

The resolution speaks to lung cancer patients in Georgia, including veterans and people of color who face documented disparities in diagnosis and survival, Georgia healthcare providers, and the medical technology company Intuitive, which is publicly commended by name.

### Why it matters

Because this is a resolution rather than a law, it does not require any agency to act, fund any program, or change any patient's care. Its practical effect is a public statement of concern about lung cancer outcomes in Georgia and recognition of a specific company's technology.

### Key provisions

- The preamble cites national and Georgia-specific statistics on lung cancer deaths, diagnosis rates, survival rates, and disparities by race and veteran status.
- The first resolving clause states the Senate's recognition of lung cancer as a public health concern and support for prevention and early detection efforts.
- The second resolving clause commends Intuitive specifically for the Ion robotic endoluminal system and da Vinci surgical system.
- The final clause directs the Secretary of the Senate to distribute a copy of the resolution to Intuitive.

## Status

- Status: Passed (2026-01-29)
- Last action: Senate Read and Adopted (2026-01-29)
- Sponsors: Chuck Hufstetler, Bo Hatchett, Max Burns, Ben Watson, Carden Summers, John Albers, Larry Walker, Shawn Still, Jason Anavitarte, Blake Tillery, Frank Ginn, Clint Dixon, Steve Gooch, Kay Kirkpatrick, Lee Anderson, Billy Hickman, Marty Harbin, Bill Cowsert, Chuck Payne, Matt Brass, Timothy Bearden, Russ Goodman
- Official page: https://www.legis.ga.gov/legislation/72499

> The history, votes, and amendments (94 characters) are at https://georgiacommons.org/bills/2025-2026/sr634.md?full=1
